ALTA WOLDE: Open Payments
NPI 1295308245 · GERMANTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,169 in 46 payments from 13 companies in 2025. Trend: 2023 $1,382 · 2024 $1,154 · 2025 $1,169
Food & beverage: $1,162Education: $7
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $352 |
| AstraZeneca Pharmaceuticals LP | 12 | $263 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $100 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| GENZYME CORPORATION | 2 | $71 |
| BioCryst US Sales Co., LLC | 3 | $68 |
| Optinose US, Inc. | 3 | $52 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Organon LLC | 2 | $33 |
| Grifols USA, LLC | 1 | $32 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, AIRSUPRA, ORLADEYO, TRELEGY ELLIPTA, Xhance, FASENRA.
Industry payments across MD — which companies pay providers there.
